发明名称 |
Use of soluble CD14 for treatment of type 2 diabetes mellitus |
摘要 |
Use of soluble CD14 (sCD14) for the manufacture of a medicament for therapeutic or preventive treatment of a disease involving a chronic inflammation condition and a clinical disorder associated with insulin resistance in an animal or a human. Examples of diseases include type 2 diabetes mellitus, obesity, metabolic syndrome, arteriosclerotic disease, arterial hypertension and functional ovaric hyperandrogenism.
|
申请公布号 |
US7655237(B2) |
申请公布日期 |
2010.02.02 |
申请号 |
US20040550265 |
申请日期 |
2004.02.23 |
申请人 |
BRIDGE BIORESEARCH LIMITED |
发明人 |
FERNANDEZ-REAL JOSE;ENGEL WIFREDO |
分类号 |
A61K39/00;A01K67/027;A61K38/17 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|